| Dr Roy Lipworth, MD | |
|
280 Exempla Cir, Lafayette, CO 80026-3370 | |
| (303) 338-4545 | |
| Not Available |
| Full Name | Dr Roy Lipworth |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 6 Years |
| Location | 280 Exempla Cir, Lafayette, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043716327 | NPI | - | NPPES |
| 029419 | Other | CO | KAISER COMMERCIAL NUMBER |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Colorado Permanente Medical Group Pc | 1254238454 | 1113 |
News Archive
Allos Therapeutics, Inc. announced today that the Agreement and Plan of Merger and Reorganization entered into by and among Allos, AMAG and Alamo Acquisition Sub, Inc. on July 19, 2011, as amended on August 8, 2011, has been terminated.
USA Today: "Five years later, Hurricane Katrina continues to wreak havoc in the lives of thousands of children who suffer from serious emotional disturbances, often compounded by a lack of stable housing, a study reports today.
The selective sphingosine 1-phosphate receptor inhibitor ozanimod significantly reduces lesion activity in patients with relapsing-remitting multiple sclerosis, shows a phase II study published in The Lancet Neurology.
The development of almost all cancer is influenced by environmental factors, argues Dr Günter Obe and co-editors in their new title Cancer Risk Evaluation: Methods and Trends. However, while some environmental factors, such as smoking or ionizing radiation, puts the vast majority of humans at risk regardless of their genetic background, many other risk factors such as hazardous working conditions, increase the cancer risk for smaller groups of the population and are often dependent on additional factors as well as an individual's genetics.
› Verified 9 days ago
| Entity Name | Colorado Permanente Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760599724 PECOS PAC ID: 1254238454 Enrollment ID: O20031216000640 |
News Archive
Allos Therapeutics, Inc. announced today that the Agreement and Plan of Merger and Reorganization entered into by and among Allos, AMAG and Alamo Acquisition Sub, Inc. on July 19, 2011, as amended on August 8, 2011, has been terminated.
USA Today: "Five years later, Hurricane Katrina continues to wreak havoc in the lives of thousands of children who suffer from serious emotional disturbances, often compounded by a lack of stable housing, a study reports today.
The selective sphingosine 1-phosphate receptor inhibitor ozanimod significantly reduces lesion activity in patients with relapsing-remitting multiple sclerosis, shows a phase II study published in The Lancet Neurology.
The development of almost all cancer is influenced by environmental factors, argues Dr Günter Obe and co-editors in their new title Cancer Risk Evaluation: Methods and Trends. However, while some environmental factors, such as smoking or ionizing radiation, puts the vast majority of humans at risk regardless of their genetic background, many other risk factors such as hazardous working conditions, increase the cancer risk for smaller groups of the population and are often dependent on additional factors as well as an individual's genetics.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Roy Lipworth, MD 10350 E Dakota Ave, Denver, CO 80247-1314 Ph: () - | Dr Roy Lipworth, MD 280 Exempla Cir, Lafayette, CO 80026-3370 Ph: (303) 338-4545 |
News Archive
Allos Therapeutics, Inc. announced today that the Agreement and Plan of Merger and Reorganization entered into by and among Allos, AMAG and Alamo Acquisition Sub, Inc. on July 19, 2011, as amended on August 8, 2011, has been terminated.
USA Today: "Five years later, Hurricane Katrina continues to wreak havoc in the lives of thousands of children who suffer from serious emotional disturbances, often compounded by a lack of stable housing, a study reports today.
The selective sphingosine 1-phosphate receptor inhibitor ozanimod significantly reduces lesion activity in patients with relapsing-remitting multiple sclerosis, shows a phase II study published in The Lancet Neurology.
The development of almost all cancer is influenced by environmental factors, argues Dr Günter Obe and co-editors in their new title Cancer Risk Evaluation: Methods and Trends. However, while some environmental factors, such as smoking or ionizing radiation, puts the vast majority of humans at risk regardless of their genetic background, many other risk factors such as hazardous working conditions, increase the cancer risk for smaller groups of the population and are often dependent on additional factors as well as an individual's genetics.
› Verified 9 days ago
Dr. Jonathan F Masoudi, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 | |
Dr. Nasim Zabihi, M.D. Urology Medicare: Medicare Enrolled Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-861-3406 | |
George Stark, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 2594 Trailridge Dr E, Lafayette, CO 80026 Phone: 303-449-7740 | |
Shunta Taylor, Urology Medicare: Not Enrolled in Medicare Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-743-5855 | |
Emilia Ripoll, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 120 Old Laramie Trail East, Lafayette, CO 80026 Phone: 303-444-0840 Fax: 303-444-0838 | |
Julio Tian-fa Chong, Urology Medicare: Accepting Medicare Assignments Practice Location: 300 Exempla Cir Ste 250, Lafayette, CO 80026 Phone: 720-536-3011 Fax: 303-468-5117 |